We have ASCO this weekend. Is anything new expected regarding their abstracts and orphan drug status? What about liquidity - they said they have cash through 2015/Q3, but after that what's next?
I have been in/out of this name multiple times and feel this weekend they could unload some big info. Looking for thoughts... Thanks
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.